However, a recent systematic review of 4995 clinical isolates in 29 studies from 1988 to 2017 revealed that fluconazole nonsusceptible Cryptococcus neoformans and Cryptococcus gattii isolates ranged from 0%–50% with a mean prevalence of 12%, and an increasing trend over time [ 9 ].
← all excerpts
Minimum Inhibitory Concentration Distribution of Fluconazole against Cryptococcus Species and the Fluconazole Exposure Prediction Model.
1
—
—